March 19, 2018 / 11:07 AM / 3 months ago

BRIEF-Pain Therapeutics Announces FDA Advisory Committee Meeting For Remoxy ER

March 19 (Reuters) - Pain Therapeutics Inc:

* PAIN THERAPEUTICS ANNOUNCES FDA ADVISORY COMMITTEE MEETING FOR REMOXY ER®

* PAIN THERAPEUTICS INC - TENTATIVE DATE FOR FDA MEETING IS JUNE 26

* PAIN THERAPEUTICS INC - PRESCRIPTION DRUG USER FEE ACT (PDUFA) TARGET DATE FOR REMOXY NDA IS AUGUST 7 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below